Tran Catherine G, Sherman Scott K, Howe James R
Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Ann Surg Oncol. 2022 Jan;29(1):85-86. doi: 10.1245/s10434-021-10859-5. Epub 2021 Oct 4.
Optimal management of duodenal neuroendocrine tumors (DNETs) has not been well-defined, especially for DNETs 1-2 cm in size. Recent studies comparing endoscopic mucosal resection (EMR) and surgical resection demonstrate EMR is safe and effective for these intermediate-sized DNETs. Expert and consensus guidelines could consider updating recommendations to reflect the outcomes of EMR in DNETs and the importance of endoscopic surveillance in these patients to evaluate for local recurrence.
十二指肠神经内分泌肿瘤（DNETs）的最佳管理尚未明确界定，尤其是对于大小为1 - 2厘米的DNETs。最近比较内镜黏膜切除术（EMR）和手术切除的研究表明，EMR对于这些中等大小的DNETs是安全有效的。专家和共识指南可考虑更新建议，以反映EMR在DNETs中的治疗效果以及内镜监测在这些患者中评估局部复发的重要性。
